摘要
目的化学合成胸腺体液因子(THF-γ2),并建立纯化、分析和活性测定的方法。方法采用Fmoc固相合成法(SPPS)合成了胸腺体液因子,用中压液相(MPLC)反相柱一步纯化,经HPLC分析纯度,通过质谱和氨基酸序列测定鉴定合成产物。根据THF-γ2促进T细胞产生IL-2的特性检测合成产物的体外活性。结果化学合成胸腺体液因子的产率为95.8%。纯化后其纯度达到95.92%。质谱测定其相对分子质量为918,与理论相对分子质量相符。氨基酸序列测定为NH2/Leu-Glu-Asp-Gly-Pro-Lys-Phe-Leu,与设计序列一致。当THF-γ2浓度为300μg·L-1时,小鼠脾细胞产生IL-2的浓度最高,为空白对照的1.9倍。结论在国内首次建立了胸腺体液因子(THF-γ2)从合成、纯化、分析到活性测定的方法,为胸腺体液因子的进一步研究和应用打下了基础。
Abstract
OBJECTIVE To study the synthesis,purification,analysis and activity determination of Thymus Humoral Factor(THF-γ2).METHODS Thymus Humoral Factor(THF-γ2) was synthesized by FmocSPPS,purified by MPLC,and identified by HPLC,MS and amino acid sequence determination.The biological activity of THF-γ2 was measured according to its characteristics of promoting IL-2 production in mouse spleen cells. RESULTS The purity of the product was 95.92%,the molecular mass was 918,and the amino acid sequence was NH2/Leu-Glu-Asp-Gly-Pro-Lys-Phe-Leu.In the concentration of 300 μg·L-1,the activity was largest and 1.9 times as much as the control.CONCLUSION The methods of the synthesis,purification,analysis and activity determination of Thymus Humoral Factor(THF-γ2) are established for further research and applications in China.
关键词
胸腺体液因子 /
Fmoc /
IL-2
{{custom_keyword}} /
Key words
thymus humoral factor /
Fmoc /
IL-2
{{custom_keyword}} /
廖晓全;赵宗阁;周立娜;徐康森;袁勤生.
胸腺体液因子(THF-γ2)的合成和活性测定[J]. 中国药学杂志, 2006, 41(07): 548-550
LIO Xio-qun;ZHO Zong-ge;ZHOU Li-n;XU Kng-sen;YUN Qin-sheng.
Synthesis and Activity Determination of Thymus Humoral Factor(THF-γ2) [J]. Chinese Pharmaceutical Journal, 2006, 41(07): 548-550
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ZHANG F G， LIU D X. Development of thymus and thymic factors[J] .Foreign Med Sci(Immunol)(国外医学·免疫学分册)，1996（4）：187-191.
[2] BURSTEIN Y， BUCHNER V， PECHT M， et al. Thymic Humoral Factor γ2: Purification and amino acid sequence of an immunoregulatory peptide from calf thymus[J] . Biochemistry， 1988， 27(11): 4066-4071.
[3] HANDZEL Z T, BURSTEIN Y, BUCHNER V，et al. Immunomodulation of T cell deficiency in humans by thymic humoral factor：from crude extract to synthetic thymic humoral factor -γ2[J] . J Biol Response Mod，1990， 9(3): 269-278.
[4] OPHIR R， PECHT M， RASHID G，et al. A synthetic thymic hormone， THF-γ2， repairs immunodeficiency of mice cured of plasmacytoma by melphalan[J] . Int J Cancer， 1990，45：1190-1194.
[5] HANDZEL Z T， ELITSUR Y， ALGRIMAWI S，et al. Treatment of congenital immune deficiencies with a thymic hormone thymic humoral factor[J] .Isr J Med Sci，1986，22：387-392.
[6] ZAIZOV R， VOGEL R， COHEN I J，et al. The immunomodulatory effect of THF in children with acute myelogenous leukemia. In: Serrou B， Rosenfeld C，eds. New trends in human immunology and cancer immunotherapy[C] . Paris：Doin Editeurs， 1980: 810-813.
[7] HANDZEL Z， BENTWICH Z， BURSTEIN R，et al. Anti-viral properties of thymic humoral factor(THF) and other thymic hormones[J] .Clin Immunol Newslett，1985，6：68-71.
[8] WYSENBEEK A J， TRAININ N， CATHCART M，et al. The influence of thymic humoral factor on systemic lupus erythematosus lymphocyte function[J] . Int J Immunoph，1985，7：603-607.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
